Institute Director
Sanja Sever, PhD
Director of the Sealy Institute for Drug Discovery · Vice President of Drug Discovery
Translational drug discovery focused on dynamin biology, cytoskeleton dynamics, endocytosis, kidney disease, and neurodegenerative disease.
Principal Investigator
Xuping Xie, PhD
Associate Professor · Scientific Director at SIDD
Antiviral and flavivirus-focused drug discovery, including mechanistic studies and therapeutic development in microbiology and immunology.
Principal Investigator
Hugues Fausther-Bovendo, PhD
Assistant Professor
Therapeutic antibody discovery and bioengineering, including monoclonal antibodies against respiratory and emerging viral pathogens.
Principal Investigator
Young-Hwan Jung, PhD
Assistant Professor
Small-molecule drug design, targeted protein degradation, epigenetic modulation, and translational programs in pain, cancer, infectious, and neurodegenerative disease.
Principal Investigator
Daniel O’Reilly, PhD
Assistant Professor
Oligonucleotide therapeutics for rare and ultra-rare disease, including chemistry, delivery, efficacy, and tissue specificity in CNS and heart targets.
Principal Investigator
Kyle Koss, PhD
Assistant Professor
Peptide and biomaterial engineering at the neuroimmune interface, with emphasis on microglia, glial scar biology, implantable devices, and biosensors.
Principal Investigator
Claudia Marino, PhD
Assistant Professor
Biophysical and biomolecular approaches to neurodegeneration, Alzheimer’s disease resilience mechanisms, and disease-modifying therapeutic development.
Principal Investigator
Lukasz Jaremko, PhD
Associate Professor · MD3 Lab
AI-augmented structure and dynamics-guided drug discovery, cancer mechanisms, spectroscopy, metabolomics, and therapeutics for difficult targets.
Institute Director
Sanja Sever, PhD
Director of the Sealy Institute for Drug Discovery · Vice President of Drug Discovery
Translational drug discovery focused on dynamin biology, cytoskeleton dynamics, endocytosis, kidney disease, and neurodegenerative disease.
Principal Investigator
Xuping Xie, PhD
Associate Professor · Scientific Director at SIDD
Antiviral and flavivirus-focused drug discovery, including mechanistic studies and therapeutic development in microbiology and immunology.
Principal Investigator
Hugues Fausther-Bovendo, PhD
Assistant Professor
Therapeutic antibody discovery and bioengineering, including monoclonal antibodies against respiratory and emerging viral pathogens.
Principal Investigator
Young-Hwan Jung, PhD
Assistant Professor
Small-molecule drug design, targeted protein degradation, epigenetic modulation, and translational programs in pain, cancer, infectious, and neurodegenerative disease.
Principal Investigator
Daniel O’Reilly, PhD
Assistant Professor
Oligonucleotide therapeutics for rare and ultra-rare disease, including chemistry, delivery, efficacy, and tissue specificity in CNS and heart targets.
Principal Investigator
Kyle Koss, PhD
Assistant Professor
Peptide and biomaterial engineering at the neuroimmune interface, with emphasis on microglia, glial scar biology, implantable devices, and biosensors.
Principal Investigator
Claudia Marino, PhD
Assistant Professor
Biophysical and biomolecular approaches to neurodegeneration, Alzheimer’s disease resilience mechanisms, and disease-modifying therapeutic development.
Principal Investigator
Lukasz Jaremko, PhD
Associate Professor · MD3 Lab
AI-augmented structure and dynamics-guided drug discovery, cancer mechanisms, spectroscopy, metabolomics, and therapeutics for difficult targets.